Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous acetaminophen + mannitol versus flurbiprofen axetil for prevention of pain after oculoplastic surgery
ChiCTR2400086066Phase 4Not yet recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Jun 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of acetaminophen, Bronchitol and flurbiprofen axetil in postoperative pain (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: NRS pain score without eye movement within 24 hours postoperatively. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
acetaminophenBronchitolflurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400086066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086066.